Guangdong Jiaying Pharmaceutical Co.Ltd(002198)
Annual report for 2021
2022007
March 2022
Section I important tips, contents and definitions
The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of the annual report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities.
Jurai, the person in charge of the company, Feng Jie, the person in charge of accounting, and Feng Jie, the person in charge of accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.
All directors have attended the meeting of the board of directors to consider this report.
If there are statements about future development in this report, which are planned matters and do not constitute the company’s substantive commitment to investors, please pay attention to the investment risks.
During the reporting period, there may be risks such as changes in industrial policies, concentration of leading products, price decline, cost control and new drug development. For details, please refer to the relevant description of the possible risks faced by the company in “Xi. Prospects for the future development of the company” in Section III “management discussion and analysis” of this report. Please pay attention to the investment risks.
The company plans not to distribute cash dividends, bonus shares or increase share capital with provident fund.
catalogue
Section I important tips, contents and definitions Wrong! No bookmarks defined. Section II Company Profile and main financial indicators Wrong! No bookmarks defined. Section III Management Discussion and Analysis Wrong! No bookmarks defined. Section IV corporate governance Wrong! No bookmarks defined. Section V environmental and social responsibility Wrong! No bookmarks defined. Section VI important matters Wrong! No bookmarks defined. Section VII changes in shares and shareholders Wrong! No bookmarks defined. Section 8 preferred shares Wrong! No bookmarks defined. Section IX relevant information of bonds Wrong! No bookmarks defined. Section x financial report Wrong! No bookmarks defined.
Directory of documents for future reference
1、 Accounting statements containing the signatures and seals of the person in charge of the company, the person in charge of accounting work and the person in charge of accounting institutions; 2、 The original of the audit report sealed by the accounting firm and signed and sealed by the certified public accountant;
3、 The originals of all company documents and announcements publicly disclosed on the information disclosure carrier designated by the CSRC during the reporting period.
4、 Other relevant documents.
The above documents are complete and available for inspection in the Securities Department of the company.
interpretation
Explanatory item refers to the explanatory content
The company, the company and Guangdong Jiaying Pharmaceutical Co.Ltd(002198) refer to Guangdong Jiaying Pharmaceutical Co.Ltd(002198)
Jiaying pharmaceutical refers to Guangdong Jiaying Pharmaceutical Co., Ltd
Jiaying great health refers to Jiaying (Shenzhen) great health development Co., Ltd
Jiahui financial leasing refers to Guangdong Jiahui Financial Leasing Co., Ltd
Hunan Jinsha and Jinsha pharmaceutical refer to Hunan Jinsha Pharmaceutical Co., Ltd
Huaqingyuan biotechnology refers to Guangdong Huaqingyuan Biotechnology Co., Ltd
Kangci medical refers to Guangdong kangci Medical Management Co., Ltd
Kangci hospital refers to Guangdong kangci brain degenerative disease hospital
CSRC refers to Guangdong securities regulatory bureau of China Securities Regulatory Commission
Shenzhen stock exchange refers to Shenzhen Stock Exchange
GMP refers to the good manufacturing practice
New south medical investment refers to Guangdong New South Medical Investment Development Co., Ltd
Zhonglian Jixin refers to Zhonglian Jixin Investment Management Co., Ltd
Laohuhui refers to Shenzhen laohuhui Asset Management Co., Ltd
Jiangsu China Pharmaceutical University Holding Co., Ltd
Changsha Dabang refers to Changsha Dabang daily necessities Trading Co., Ltd
Yaozhuang biotechnology refers to Guangdong Yaozhuang Biotechnology Co., Ltd
Section II Company Profile and main financial indicators
1、 Company information
Stock abbreviation Guangdong Jiaying Pharmaceutical Co.Ltd(002198) stock code Guangdong Jiaying Pharmaceutical Co.Ltd(002198)
Shenzhen Stock Exchange
Chinese name of the company Guangdong Jiaying Pharmaceutical Co.Ltd(002198)
Chinese abbreviation of the company Guangdong Jiaying Pharmaceutical Co.Ltd(002198)
Foreign language name of the company (if any) Guangdong Jiaying Pharmaceutical Co, Abbreviation of foreign name of Ltd Company (if any) jypc
Jurai, the legal representative of the company
Registered address: Zone B, Dongsheng Industrial Park, Meizhou City, Guangdong Province
Postal code of registered address: 514021
The historical change of the company’s registered address is not applicable
Office address: Zone B, Dongsheng Industrial Park, Meizhou City, Guangdong Province
Postal code of office address: 514021
Company website http://gdjyzy.com.cn./
E-mail [email protected].
2、 Contact person and contact information
Secretary of the board of directors and securities affairs representative
Name: Huang Xiaoliang, Chen Yuqiang
Contact address: Guangdong Jiaying, zone B, Dongsheng Industrial Park, Meizhou City, Guangdong Province
Tel: 07532321916
Fax: 07532321916
E-mail [email protected]. [email protected].
3、 Information disclosure and preparation location
The websites of the stock exchange where the company discloses the annual report include securities times, China Securities Journal and Securities Daily
Media name and website of the annual report disclosed by the company http://www.cn.info.com.cn.
The company’s annual report is prepared at Guangdong Jiaying Pharmaceutical Co.Ltd(002198) securities department, zone B, Dongsheng Industrial Park, Meizhou City, Guangdong Province
4、 Registration changes
Organization Code: 91441400748 Rendong Holdings Co.Ltd(002647) k
Changes in the company’s main business since its listing (if any)
On December 1, 2016, the former controlling shareholder Huang xiaobiao and huhuhuhui signed the share transfer agreement of Guangdong Guangdong Jiaying Pharmaceutical Co.Ltd(002198) Co., Ltd. and transferred their 57200000 shares of the company (accounting for 11.27% of the total share capital of the company) to huhuhui by means of agreement transfer, The transfer price is 18.30 yuan / share, and the total price of the changes (if any) of the previous controlling shareholders of the transferred shares is 1046760000 yuan.
On February 23, 2017, China Securities Depository and Clearing Co., Ltd. issued the confirmation of securities transfer registration, so far the share transfer registration procedures of the above agreement transfer have been completed. Huang xiaobiao is no longer the controlling shareholder and actual controller of Guangdong Jiaying Pharmaceutical Co.Ltd(002198) company. Although tiger exchange has become the largest shareholder of Guangdong Jiaying Pharmaceutical Co.Ltd(002198) through the transfer of the above shares, it is still unable to actually control Guangdong Jiaying Pharmaceutical Co.Ltd(002198) , Guangdong Jiaying Pharmaceutical Co.Ltd(002198) currently has no controlling shareholder and actual controller.
5、 Other relevant information: accounting firm employed by the company
Name of accounting firm: zhongxinghua accounting firm (special general partnership)
Office address of the accounting firm: 20th floor, South Building, building 1, yard 20, Lize Road, Fengtai District, Beijing
Name of signature accountant: Huang Hui, Xiao Guoqiang
Recommendation agencies hired by the company to perform continuous supervision duties during the reporting period □ applicable √ not applicable to financial consultants hired by the company to perform continuous supervision duties during the reporting period □ applicable √ not applicable VI. major accounting data and financial indicators whether the company needs to retroactively adjust or restate the accounting data of previous years □ yes √ no
20212020 year-on-year increase or decrease 2019
Operating income (yuan): 5747133870854472897912 5.50% 50050400447
Net profit attributable to shareholders of listed companies
(yuan) 1477269721983834825 – 92.55% – 12218447840
Deduction attributable to shareholders of listed companies
Net profit of recurring profit and loss (yuan): 282064411999175809% – 98.59% – 12399725740
Net cash flow from operating activities
(yuan) 51800132359687355055 – 46.53% 1296392139
Basic earnings per share (yuan / share) 0.0029 0.0391 -92.58% – 0.2408
Diluted earnings per share (yuan / share) 0.0029 0.0391 -92.58% – 0.2408
Weighted average return on net assets 0.22% – 2.95% – 2.73% – 16.87%
End of 2021
